Company Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 11,050 10,622 11,404 11,236 5,255 5,938
Change - -3.87% 7.37% -1.47% -53.23% 12.99%
Enterprise Value (EV) 1 12,306 11,871 12,339 12,505 6,656 6,812
Change - -3.53% 3.94% 1.34% -46.78% 2.36%
P/E 71.2x 84.4x 81.6x -27x 193x -54.4x
PBR 2.84x 2.69x 2.85x 3.2x 1.65x 1.88x
PEG - -4.6x 7.3x 0x -2x 0x
Capitalization / Revenue 3.58x 3.41x 3.22x 2.64x 1.37x 1.95x
EV / Revenue 3.99x 3.82x 3.49x 2.93x 1.74x 2.23x
EV / EBITDA 42.1x 36.6x 40.4x -41.9x 53.6x 30.7x
EV / EBIT 62.6x 51.7x 60.8x -31.1x 339x 63.1x
EV / FCF 45x 76.4x 27.3x 101x 62.4x 12.1x
FCF Yield 2.22% 1.31% 3.66% 0.99% 1.6% 8.26%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 0.11 0.09 0.1 -0.3 0.02 -0.08
Distribution rate - - - - - -
Net sales 1 3,088 3,112 3,540 4,263 3,825 3,049
EBITDA 1 292.4 324.2 305.6 -298.6 124.1 221.9
EBIT 1 196.5 229.5 203 -402.3 19.62 108
Net income 1 152.4 124.2 138.2 -414.5 33.62 -104.4
Net Debt 1 1,256 1,249 935 1,268 1,400 874.7
Reference price 2 7.830 7.600 8.160 8.110 3.850 4.350
Nbr of stocks (in thousands) 14,11,200 13,97,598 13,97,598 13,85,502 13,65,010 13,65,010
Announcement Date 29/04/21 22/04/22 28/04/23 29/04/24 28/04/25 27/04/26
1CNY in Million2CNY
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 84Cr
41.43x14.03x29.73x0.48% 1,26100Cr
40.79x6.85x19.26x1.91% 67TCr
37.33x8.57x17.72x2.36% 52TCr
21.83x5.29x13.24x2.47% 39TCr
101.76x5.82x24.8x2.37% 35TCr
23.99x5.78x14.05x2.75% 30TCr
23.93x4.79x13.46x1.83% 28TCr
23.64x7.27x13.36x2.2% 25TCr
-40.04x7.4x46.61x1.94% 21TCr
Average 30.52x 7.31x 21.36x 2.03% 42TCr
Weighted average by Cap. 36.56x 8.81x 22.37x 1.7%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Guizhou Bailing Group Pharmaceutical Co., Ltd.

Historical PBR trend

Valuation ratios - PBR - Guizhou Bailing Group Pharmaceutical Co., Ltd.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Guizhou Bailing Group Pharmaceutical Co., Ltd.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Guizhou Bailing Group Pharmaceutical Co., Ltd.

  1. Stock Market
  2. Stocks
  3. 002424 Stock
  4. Valuation Guizhou Bailing Group Pharmaceutical Co., Ltd.